Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Advisorshares Pure US Cannabis ETF
(NY:
MSOS
)
4.130
-0.040 (-0.96%)
Official Closing Price
Updated: 8:00 PM EST, Dec 6, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Advisorshares Pure US Cannabis ETF
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Is MariMed A Safe Haven In The Wake Of Florida's Cannabis Legalization Defeat?
December 04, 2024
For investors, MariMed represents a fundamentally strong outlier, but industry-wide challenges remain a drag on stock performance.
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Cannabis Stocks Feel The Burn: Matt Gaetz Bows Out As Trump's Attorney General Nominee
November 21, 2024
The AdvisorShares Pure US Cannabis ETF (NYSEARCA: MSOS), often viewed as a benchmark for MSOs, dropped by -4.31%, closing at $4.56.
Via
Benzinga
Topics
Cannabis
ETFs
Government
Exposures
Cannabis
Political
Trump Nominates Another Cannabis Supporter To Cabinet: Rep. Matt Gaetz For Attorney General
November 13, 2024
Donald Trump nominated Rep. Matt Gaetz as attorney general, who has supported cannabis legalization and proposed ending cannabis testing for military recruitment.
Via
Benzinga
Topics
Cannabis
Government
Exposures
Cannabis
Political
Matt Gaetz Is Trump's Attorney General Pick: Would-Be Top Cop Is Under House Ethics Investigation
November 13, 2024
Matt Gaetz has been named the attorney general nominee by Donald Trump. The selection comes while Gaetz is being investigated by Congress.
Via
Benzinga
Topics
Government
Exposures
Political
Turnaroud Tuesday: Did Canna Finally Bottom?
November 12, 2024
MSOS rose over 14% in today’s session. Interestingly, the price action was inside the trading range of Monday.
Via
Talk Markets
Stocks Of The Day: 4-Pillar Power Plays You Can’t Miss - Today’s Biggest Movers
November 13, 2024
Markets opened with a strong tailwind, driven by the latest CPI data showing inflation in line with expectations, bolstering investor confidence.
Via
Talk Markets
Topics
Economy
Exposures
Interest Rates
Cannabis Stocks Pop Following Chris Christie's Prediction That Trump Will Deschedule Cannabis
November 12, 2024
Cannabis stocks rally on prediction of Trump descheduling marijuana; MSOS leads gains with a 15% surge, followed by Cronos at nearly 13%.
Via
Benzinga
Topics
Cannabis
Government
Exposures
Cannabis
Political
The Good, The Bad, And The Ugly: A Recap Of Post-Vote Winners & Losers
November 10, 2024
What’s promised on the campaign trail and what comes to reality are often different. But that didn’t stop investors and traders from speculating on the most prevalent themes under a new administration....
Via
Talk Markets
Cannabis Stocks: Is It Time To Buy The Dip After Elections And Legalization Setbacks?
November 07, 2024
After a post-election plunge, cannabis stocks are showing signs of recovery. We analyze Tilray, SNDL, Trulieve, MSOS – time to buy the dip?
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Cannabis Stocks Collapse After Trump Win: Major Players See Double-Digit Declines At Wednesday's Close
November 06, 2024
Following Trump's presidential election victory, the cannabis sector took a sharp downturn. Here's a summary of what happened today.
Via
Benzinga
Topics
Cannabis
Government
Exposures
Cannabis
Political
Tilray, Trulieve And Other Cannabis Stocks Nosediving As Industry Faces New Wave Of Political Uncertainty
November 06, 2024
Cannabis stocks plunge as Florida's legalization fails and GOP Senate control tempers expectations for industry growth.
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Cannabis Reform Stumbles In 2024 Elections: A State-By-State Breakdown As Stocks Take A Hit
November 06, 2024
Florida and the Dakotas reject cannabis measures, while Nebraska approves medical cannabis and Dallas decriminalizes. Explore each state's path forward.
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Marijuana Capital Markets: Bright 2025 Outlook Amid Regulatory Shifts
November 04, 2024
Federal reform and banking access may drive cannabis capital markets in 2025. Discover why upcoming election changes could boost the industry.
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Cannabis Stocks Sink Amid Broader Market Decline And Election Jitters
October 31, 2024
Cannabis stocks drop amid broader market downturn and election uncertainty, with major players like Tilray and Aurora Cannabis w/ losses.
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
AdvisorShares MSOS Climbs 8% As Cannabis Rescheduling Sparks Investor Interest
October 23, 2024
AdvisorShares MSOS ETF surges 8% as U.S. cannabis reform nears. Explore key investment signals and market opportunities.
Via
Benzinga
Topics
Cannabis
ETFs
Exposures
Cannabis
'The Biggest Opportunities For Investors Outside AI': Optimism Reigns At Benzinga Conference Amid Talks Of Cannabis Rescheduling, Tech Advances
October 11, 2024
Cannabis leaders at the Benzinga Cannabis Capital Conference see rescheduling and banking reform as game-changers for the industry.
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
EXCLUSIVE: Weed Companies Will Be Treated Like Normal Businesses Once This Tax Provision Goes Away, Experts Say
October 08, 2024
Marijuana companies would be "treated like normal businesses," If the oppressive restrictions of Section 280E of the Internal Revenue Code, which prevents cannabis businesses from deducting typical...
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Profit from the Green Wave: Top Cannabis Stocks to Watch
October 02, 2024
Fueled by evolving regulations and strong market growth, the cannabis sector has emerged as a potentially lucrative long-term investment opportunity.
Via
MarketBeat
Topics
Cannabis
Exposures
Cannabis
Cannabis Investor Sentiment Softens As Institutional Confidence Wanes, Survey Shows
September 13, 2024
Investor sentiment on cannabis turns neutral as delays in rescheduling and uplisting affect the market. Florida legalization also analyzed...
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Will The DEA Complete Cannabis Rescheduling? Hear From Experts The Day After Harris-Trump Debate
September 10, 2024
If cannabis is reclassified, the industry could see tax reforms, research opportunities, and the development of new regulatory frameworks.
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Cannabis Stocks React To Trump's Marijuana Comments: See Which Ones Posted Solid Gains
September 09, 2024
Trump confirmed his support for recreational cannabis in Florida. and sparked a reaction in the cannabis stock market on Monday.
Via
Benzinga
Topics
Cannabis
Government
Exposures
Cannabis
Political
Looking for the Next Big Growth Opportunity? It Might Not Be in Artificial Intelligence.
September 07, 2024
Investing in cannabis could be a calculated risk worth taking right now.
Via
The Motley Fool
Topics
Cannabis
Exposures
Cannabis
Trump's Marijuana Support Could Ignite Stock Surge – Are You Positioned To Benefit?
September 05, 2024
Stocks in the cannabis sector showed varied reactions on Wednesday, after Trump's comments on the legalization of marijuana in Florida.
Via
Benzinga
Topics
Cannabis
Government
Exposures
Cannabis
Political
Cheaper Than A Big Mac: Weed Penny Stocks Emerge As Winners Amidst Market Downturn
August 29, 2024
Amidst the market backdrop, a few cannabis penny stocks, priced lower than one of McDonald's (NYSE: MCD) classics, have shown resilience.
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Congressman Blumenauer Slams DEA For Postponing Marijuana Rescheduling, Places Hope In Soon-To-Be President Harris
August 28, 2024
Congressman Earl Blumenauer, a Democrat from Oregon and co-chair of the Congressional Cannabis Caucus is disappointed the U.S. Drug Enforcement Administration (DEA) opted to delay rescheduling of...
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Cannabis Stocks Plummet By Up To 16% On DEA Rescheduling Delay: Could This Be The Buying Opportunity Of 2024?
August 27, 2024
The market's response was immediate and pronounced. Cannabis stocks plummeted, with MOSOS ETF dropping over 10% in early trading.
Via
Benzinga
Topics
Cannabis
ETFs
Exposures
Cannabis
Key Cannabis Leaders Gather For Networking At Benzinga's Fall 2024 Conference: The Last Big Event Before The Election
August 26, 2024
Join cannabis industry leaders at Benzinga's Fall Conference in Chicago. Keynotes, networking, and legalization insights.
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
New SEC Filings Reveal Major Risks In Cannabis ETFs Following Recent Volatility — But There's Still Room for Optimism
August 22, 2024
Cannabis ETFs MSOS and MSOX facing regulatory uncertainty and market downturn, with potential for rebound if federal law is amended.
Via
Benzinga
Topics
Cannabis
ETFs
Regulatory Compliance
Exposures
Cannabis
Legal
Regulatory
The Florida Keys: Cannabis Legalization Brings The Sunshine State Into Focus
August 17, 2024
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
The Bay Street Butcher: A Cannabis ETF Rebalancing Triggers Volatility
August 15, 2024
How cannabis ETF volatility impacts markets amid the MJUS rebalancing. Learn how fluctuating dynamics affect cannabis stocks.
Via
Benzinga
Topics
Cannabis
ETFs
Exposures
Cannabis
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.